knowledge -WSS

knowledge

author：leisure time 2025-08-26 23:44:05 - browse：1479

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Living with Hashimoto's and celiac disease, and med school, too

leisure time

WSS

N.Y. state detects polio case, first in the U.S. since 2013

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Lung cancer is America's deadliest cancer. Yet so few get screened

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Trump's false claims about Georgia's 2020 election long debunked

Wikipedia

knowledge

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Patient advocates sound warning on FDA proposal on salt intake

Heart attack and stroke risk calculators need revising

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Medicare details structure of new drug price negotiation program

HCA discloses massive data breach affecting 11 million patients

Moonlake's readout produced a cash windfall. Risks remain

California’s proposed $25 per hour health care minimum wage

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Palantir health business leans on meeting customers’ needs

hotspot

FDA approves first treatment for ultra

Living with Hashimoto's and celiac disease, and med school, too

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Evacuations in place as 3 wildfires burn in eastern Washington state

A new study sees potential in DNA sequencing of infants

Hilary expected to bring catastrophic, life

focus

leisure time

leisure time

knowledge